Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

IMPORTANCE: The antifungal medication voriconazole is used to prevent and treat aspergillosis, a major cause of mortality among recipients of lung transplants (hereinafter referred to as lung recipients). Small studies suggest that voriconazole increases risk of cutaneous squamous cell carcinoma (SC...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Dermatol
Main Authors: D’Arcy, Monica E., Pfeiffer, Ruth M., Rivera, Donna R., Hess, Gregory P., Cahoon, Elizabeth K., Arron, Sarah T., Brownell, Isaac, Cowen, Edward W., Israni, Ajay K., Triplette, Matthew A., Yanik, Elizabeth L., Engels, Eric A.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7221851/
https://ncbi.nlm.nih.gov/pubmed/32401271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.1141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares